These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32847094)

  • 21. Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity.
    Morelli AE; Larregina AT; Smith-Arica J; Dewey RA; Southgate TD; Ambar B; Fontana A; Castro MG; Lowenstein PR
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():571-583. PubMed ID: 10091995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of flanking matrix attachment regions on the expression of microinjected transgenes during preimplantation development of mouse embryos.
    Gutiérrez-Adán A; Pintado B
    Transgenic Res; 2000 Apr; 9(2):81-9. PubMed ID: 10951692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CMV early enhancer/chicken beta actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors.
    Alexopoulou AN; Couchman JR; Whiteford JR
    BMC Cell Biol; 2008 Jan; 9():2. PubMed ID: 18190688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.
    Gu J; Kagawa S; Takakura M; Kyo S; Inoue M; Roth JA; Fang B
    Cancer Res; 2000 Oct; 60(19):5359-64. PubMed ID: 11034071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
    Gu J; Andreeff M; Roth JA; Fang B
    Gene Ther; 2002 Jan; 9(1):30-7. PubMed ID: 11850720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle creatine kinase/SV40 hybrid promoter for muscle-targeted long-term transgene expression.
    Takeshita F; Takase K; Tozuka M; Saha S; Okuda K; Ishii N; Sasaki S
    Int J Mol Med; 2007 Feb; 19(2):309-15. PubMed ID: 17203206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptional activities of human elongation factor-1α and cytomegalovirus promoter in transgenic dogs generated by somatic cell nuclear transfer.
    Eun K; Hong N; Jeong YW; Park MG; Hwang SU; Jeong YIK; Choi EJ; Olsson PO; Hwang WS; Hyun SH; Kim H
    PLoS One; 2020; 15(6):e0233784. PubMed ID: 32492024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
    Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
    J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining fibroblast isolation with lentiviral gene transfer to validate transgene expression in mice following pronucleus injection.
    Rössler OG; Lesch A; Thiel G
    Transgenic Res; 2016 Dec; 25(6):839-846. PubMed ID: 27506594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A self-augmenting gene expression cassette for enhanced and sustained transgene expression in the presence of proinflammatory cytokines.
    Luo P; Reed BD; Tsang TC; Harris DT; Flavell RA
    DNA Cell Biol; 2006 Dec; 25(12):659-67. PubMed ID: 17184167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
    Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
    J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors.
    Armentano D; Zabner J; Sacks C; Sookdeo CC; Smith MP; St George JA; Wadsworth SC; Smith AE; Gregory RJ
    J Virol; 1997 Mar; 71(3):2408-16. PubMed ID: 9032378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The EF-1α promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells.
    Wang X; Xu Z; Tian Z; Zhang X; Xu D; Li Q; Zhang J; Wang T
    J Cell Mol Med; 2017 Nov; 21(11):3044-3054. PubMed ID: 28557288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A small chimeric promoter for high prostate-specific transgene expression from adenoviral vectors.
    Kraaij R; van der Weel L; de Ridder CM; van der Korput HA; Zweistra JL; van Rijswijk AL; Bangma CH; Trapman J
    Prostate; 2007 Jun; 67(8):829-39. PubMed ID: 17394196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts.
    Panet R; Marcus M; Atlan H
    J Cell Physiol; 2000 Jan; 182(1):109-18. PubMed ID: 10567922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blastocyst Formation Rate and Transgene Expression are Associated with Gene Insertion into Safe and Non-Safe Harbors in the Cattle Genome.
    Ghahfarokhi MK; Dormiani K; Mohammadi A; Jafarpour F; Nasr-Esfahani MH
    Sci Rep; 2017 Nov; 7(1):15432. PubMed ID: 29133827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of cloned genetically modified human fibroblasts to assess long-term survival in vivo.
    Krueger GG; Jorgensen CM; Petersen MJ; Mansbridge JN; Morgan JR
    Hum Gene Ther; 1997 Mar; 8(5):523-32. PubMed ID: 9095404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transgene expression of alpha tumor necrosis factor with mutations D142N and A144R under control of human telomerase reverse transcriptase promoter eradicates well-established tumors and induces long-term antitumor immunity.
    Xiang J; Munegowda MA; Deng Y
    Cancer Gene Ther; 2009 May; 16(5):430-8. PubMed ID: 19096444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing and suppressing effects of dexamethasone on transgene expression in vitro.
    Akahane M; Kuriyama S; Ohgushi H; Akahane T; Kawamura K; Watanabe S; Funakoshi F; Yoshiji H; Ikenaka K; Takakura Y
    Int J Mol Med; 2002 Jul; 10(1):107-12. PubMed ID: 12060860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of adenovirus-encoded transgenes from the cytomegalovirus immediate early promoter in irradiated tumor cells.
    Tang DC; Jennelle RS; Shi Z; Garver RI; Carbone DP; Loya F; Chang CH; Curiel DT
    Hum Gene Ther; 1997 Nov; 8(17):2117-24. PubMed ID: 9414259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.